Tusk Therapeutics Ltd.
Records under this name other than the patents Tusk Therapeutics Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 13 patents it holds.
Showing 1 to 2 of 2 · Back to Tusk Therapeutics Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| 16/628,713 | Compounds and Methods for Tumour-Specific Cell Depletion now held by Cancer Research Technology Limited Abandoned Abandoned Apr 1, 2025 | Abandoned | Abandoned Apr 1, 2025 | |
| 18/470,875 | ANTI-CD25 Antibody Agents Abandoned Abandoned Oct 2, 2026 | Abandoned | Abandoned Oct 2, 2026 |